iRay Technology Co., Ltd. (688301) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of 20.57% and Operating profit at 15.21% over the last 5 years

The company has declared Negative results for the last 3 consecutive quarters

With ROE of 9.68%, it has a very expensive valuation with a 4.61 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 22,366 Million (Large Cap)

P/E

48.00

Industry P/E

Dividend Yield

0.64%

Debt Equity

0.23

Return on Equity

9.68%

Price to Book

4.61

Revenue and Profits:

Net Sales:

579 Million

(Quarterly Results - Jun 2025)

Net Profit:

189 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-12.82%

6 Months

10.38%

1 Year

26.81%

2 Years

-6.84%

3 Years

-39.62%

4 Years

-47.74%

5 Years

36.84%

iRay Technology Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

iRay Technology Hits Day High with 4.38% Surge, Outperforming Market

iRay Technology Co. has experienced notable stock performance, gaining 4.38% on October 24, 2025, and reaching an intraday high of CNY 120.28. Despite a 27.8% decline in profits over the past year, the company has shown strong sales growth and impressive year-to-date returns.

iRay Technology Co. Hits Day Low of CNY 111.50 Amid Price Pressure

iRay Technology Co., Ltd. faced a notable stock decline on October 13, 2025, amid challenges in the Pharmaceuticals & Biotechnology sector. Despite a strong year-to-date performance, the company reported a significant profit drop and maintains a high price-to-earnings ratio, reflecting its premium valuation amidst market volatility.

iRay Technology Hits Day Low of CNY 113.63 Amid Price Pressure

iRay Technology Co., Ltd. saw its stock price decline significantly today, contrasting with the broader market. Despite a strong annual return of over 61%, the company has faced challenges, including three consecutive quarters of negative results and a notable profit decline. Financial metrics indicate a high valuation and conservative leverage.

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

20.57%

EBIT Growth (5y)

15.21%

EBIT to Interest (avg)

50.07

Debt to EBITDA (avg)

0.83

Net Debt to Equity (avg)

0.29

Sales to Capital Employed (avg)

0.27

Tax Ratio

11.38%

Dividend Payout Ratio

21.90%

Pledged Shares

Institutional Holding

ROCE (avg)

32.57%

ROE (avg)

13.25%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

4.61

EV to EBIT

60.37

EV to EBITDA

44.71

EV to Capital Employed

3.94

EV to Sales

12.64

PEG Ratio

Dividend Yield

0.64%

ROCE (Latest)

6.52%

ROE (Latest)

9.68%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 8.79% vs 3.42% in Jun 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 16.05% vs -11.06% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "579.40",
          "val2": "532.60",
          "chgp": "8.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "219.50",
          "val2": "165.60",
          "chgp": "32.55%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.50",
          "val2": "8.00",
          "chgp": "-68.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-5.60",
          "val2": "-26.20",
          "chgp": "78.63%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "189.40",
          "val2": "163.20",
          "chgp": "16.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "304.90%",
          "val2": "271.20%",
          "chgp": "3.37%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.79% vs 20.41% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is -25.53% vs -5.31% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,820.50",
          "val2": "1,853.60",
          "chgp": "-1.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "487.70",
          "val2": "676.30",
          "chgp": "-27.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "29.80",
          "val2": "26.60",
          "chgp": "12.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-49.00",
          "val2": "-76.00",
          "chgp": "35.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "450.40",
          "val2": "604.80",
          "chgp": "-25.53%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "216.90%",
          "val2": "325.10%",
          "chgp": "-10.82%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Jun'25

Jun'24

Change(%)

Net Sales

579.40

532.60

8.79%

Operating Profit (PBDIT) excl Other Income

219.50

165.60

32.55%

Interest

2.50

8.00

-68.75%

Exceptional Items

-5.60

-26.20

78.63%

Consolidate Net Profit

189.40

163.20

16.05%

Operating Profit Margin (Excl OI)

304.90%

271.20%

3.37%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Jun 2025 is 8.79% vs 3.42% in Jun 2024

Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 16.05% vs -11.06% in Jun 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

1,820.50

1,853.60

-1.79%

Operating Profit (PBDIT) excl Other Income

487.70

676.30

-27.89%

Interest

29.80

26.60

12.03%

Exceptional Items

-49.00

-76.00

35.53%

Consolidate Net Profit

450.40

604.80

-25.53%

Operating Profit Margin (Excl OI)

216.90%

325.10%

-10.82%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -1.79% vs 20.41% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is -25.53% vs -5.31% in Dec 2023

All Annual Results

Company CV

About iRay Technology Co., Ltd.

iRay Technology Co., Ltd.

Pharmaceuticals & Biotechnology

No Details Available.

Company Coordinates

No Company Details Available

iRay Technology Co., Ltd.

1Day

52 Week

CASH

FII

DII

Promoter

MarketsMojo — Loved in India, Now Global

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of 20.57% and Operating profit at 15.21% over the last 5 years

The company has declared Negative results for the last 3 consecutive quarters

With ROE of 9.68%, it has a very expensive valuation with a 4.61 Price to Book Value

Market Beating Performance

Mojo Parameters

Stock DNA

Total Returns (Price + Dividend)

Risk Adjusted Returns v/s

News

iRay Technology Hits Day High with 4.38% Surge, Outperforming Market

iRay Technology Co. Hits Day Low of CNY 111.50 Amid Price Pressure

iRay Technology Hits Day Low of CNY 113.63 Amid Price Pressure

Announcements

Corporate Actions

Quality key factors

Valuation key factors

Technicals key factors

Shareholding Snapshot

Shareholding Compare (%holding)

Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY

Annual Results Snapshot (Consolidated) - Dec'24

About iRay Technology Co., Ltd.

Company Coordinates